scispace - formally typeset
R

Roberta Rudà

Researcher at University of Turin

Publications -  241
Citations -  7454

Roberta Rudà is an academic researcher from University of Turin. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 37, co-authored 194 publications receiving 4805 citations. Previous affiliations of Roberta Rudà include University of Southern California.

Papers
More filters
Journal ArticleDOI

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

TL;DR: The IELSG32 trial provides a high level of evidence supporting the use of MATRix combination as the new standard chemoimmunotherapy for patients aged up to 70 years with newly diagnosed primary CNS lymphoma and as the control group for future randomised trials.